Maripau Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$378K Sell
411
-30
-7% -$30.4K 0.17% 106
2025
Q4
$474K Buy
441
+66
+18% +$63.1K 0.22% 90
2025
Q3
$286K Sell
375
-22
-6% -$16.4K 0.14% 115
2025
Q2
$307K Buy
+397
New +$308K 0.15% 119

Other funds holding LLY

Maripau Wealth Management's LLY Position: Q1 2026 in Review

Maripau Wealth Management reduced its Eli Lilly (LLY) stake by 6.8% in Q1 2026, selling an estimated $30.4K and leaving 411 shares worth $378K. The position accounts for 0.17% of the portfolio, ranked #106.

Maripau Wealth Management first reported a position in LLY in Q2 2025 and has held it in 4 quarters since. The position peaked at $474K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Maripau Wealth Management held 411 shares of Eli Lilly worth $378K as of Q1 2026.
  • Maripau Wealth Management sold 30 Eli Lilly shares in Q1 2026, an estimated $30.4K.
  • Eli Lilly made up 0.17% of Maripau Wealth Management's portfolio in Q1 2026, its #106 holding.
  • Maripau Wealth Management first reported a position in Eli Lilly in Q2 2025 and has held it in 4 quarters since.
  • Maripau Wealth Management's Eli Lilly position peaked at $474K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Maripau Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.